This section will contain updates from the pain industry.

Free Live Webinar on Tax Reduction, Estate Planning, and Lawsuit Prevention June 24, 6 pm CT

We're pleased to let you know this webinar, originally scheduled for last month, will now take place on June 24. To help mitigate the impact of COVID-19, the tax deadline was extended to July 15 year. On Wednesday, June ...
Continue reading

Free Live Webinar on Tele-PainCare May 27, 6 pm CT

This one-hour webinar is sponsored by Harvard Medtech and introduces a proven, innovative Tele-PainCare™ program that allows physician practices to generate immediate revenue by managing their patients' pain in the safet...
Continue reading

AAPM 2020 Resource Center Highlights

The AAPM 2020 Resource Center featured 65 companies presenting their products and services,160 scientific posters, and networking events – including popular Meet the Faculty sessions – held throughout the meeting. Learn ...
Continue reading
Topics:

FDA Approves Lundbeck’s Vyepti™ (eptinezumab-jjmr) – the First and Only Intravenous Preventive Treatment for Migraine

Read the full story .  
Topics:

FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis

​ Read the full story . 
Topics:

AAPM 2020 Ultrasound Preconference Course Supporters

On February 27, AAPM will feature the 2020 Advanced Ultrasound-Guided Pain Medicine Interventions preconference course. We would like to thank our Commercial Supporters for their dedication to pain medicine education by ...
Continue reading

More than 70 Industry Partners to Exhibit at AAPM 2020 Next Week

Preview a list of companies that will be exhibiting at the AAPM Annual Meeting February 27-March 1 in National Harbor. Learn about your therapeutic options for the treatment of acute and chronic pain. 

Continue reading
Topics:

BioElectronics Announces FDA Market Clearance for Over-The-Counter Treatment of Musculoskeletal Pain

BioElectronics Corporation is pleased to announce that it has obtained a new 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new, over-the counter marketing clearance was granted for the drug...
Continue reading

Lilly's REYVOW™ (lasmiditan) C-V, the First and Only Medicine in a New Class of Acute Treatment for Migraine (ditan), Now Available for Prescription

Eli Lilly and Company announced today that REYVOW™ (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment of migraine with or without aura in adults, is now available for prescription and w...
Continue reading
Topics:

Novel Gene Therapies for Precision Pain Management Published by Pharmafile

 Article emphasizes the need of alternative approaches to manage pain and specifically focuses on the genetics of pain and gene therapy solutions. Full story.  
Topics:

Want more pain resources? Check out our library of on-demand education, upcoming events, and more.

Learn More